An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa. [PDF]
Contraception, 2018 Bertrand JT +5 more
europepmc +2 more sources
PLoS ONE, 2022 Objective While self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has well-documented benefits, uptake may be improved by addressing client concerns such as fear of self-injury and low self-efficacy.
Holly M. Burke +7 more
doaj +2 more sources
Sexual & reproductive health self-care measurement tool [PDF]
, 2023 The Sexual and Reproductive Health Self-Care Measurement Tool aims to provide a global standard approach to practical and accurate measurement of sexual and reproductive (SRH) self-care interventions, with a focus on three specific interventions: self ...
El-Osta, A, Rothschild, C, Sedgh, G
core +1 more source
Is self-administered DMPA an answer to contraception access in the post-Roe era? [PDF]
, 2023 Consider prescribing self-administered subcutaneous depot medroxyprogesterone acetate (DMPA) for contraception instead of provider-administered DMPA. Self-administration improves contraception continuation rates without notable increases in pregnancy or ...
Castelli, Gregory, Nakaishi, Lindsay
core +2 more sources
Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC). [PDF]
Eval Program Plann, 2018 In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016.
Stout A +5 more
europepmc +3 more sources
Contraceptive self-injection knowledge, attitude and practices among female students of a tertiary health institution in south west Nigeria [PDF]
, 2022 Background: Contraception is one of the key strategies to achieving sustainable developments but access has been low among youths in developing countries.
Awubite, Loliya Esther +3 more
core +2 more sources
Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers. [PDF]
Contraception, 2018 To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC.This article compares results from interviews with DMPA-SC providers in two separate pilot studies: 1) 53 medical and nursing ...
Hernandez JH +5 more
europepmc +4 more sources
Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda. [PDF]
Contracept X, 2019 Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of Congo (DRC) and Uganda, we measured trends in DMPA-SC and identified characteristics associated with DMPA-SC ...
Anglewicz P +7 more
europepmc +4 more sources
Systematic Reviews, 2023 Background Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, continuation, and autonomy.
Adeniyi Kolade Aderoba +2 more
doaj +1 more source
Reproductive Health, 2022 Plain language summary Self-injectable contraception (DMPA-SC) has the potential to expand family planning access. Once users are trained to self-inject, they can obtain multiple units and self-inject every three months privately, without needing to ...
Lucy W. Ruderman +4 more
doaj +1 more source